Jim Simons Dyadic International Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dyadic International Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 23,000 shares of DYAI stock, worth $39,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,000

Previous 21,200 8.49%

Holding current value

$39,100

Previous $31,000 25.81%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.04 - $1.55 $1,872 - $2,790	1,800 Added 8.49%	23,000 $23,000
Q2 2024 Aug 09, 2024	BUY	$1.39 - $2.27 $5,977 - $9,761	4,300 Added 25.44%	21,200 $31,000
Q1 2024 May 13, 2024	BUY	$1.29 - $1.67 $1,935 - $2,505	1,500 Added 9.74%	16,900 $28,000
Q4 2023 Feb 13, 2024	BUY	$1.52 - $2.04 $6,688 - $8,976	4,400 Added 40.0%	15,400 $25,000
Q3 2023 Nov 14, 2023	BUY	$1.71 - $2.08 $18,810 - $22,880	11,000 New	11,000 $21,000
Q3 2021 Nov 12, 2021	SELL	$3.3 - $6.49 $251,460 - $494,538	-76,200 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.35 - $5.67 $126,630 - $214,326	37,800 Added 98.44%	76,200 $274,000
Q1 2021 May 13, 2021	BUY	$4.75 - $6.87 $52,592 - $76,064	11,072 Added 40.52%	38,400 $211,000
Q4 2020 Feb 10, 2021	BUY	$5.35 - $7.77 $146,204 - $212,338	27,328 New	27,328 $147,000
Q1 2020 May 14, 2020	SELL	$2.58 - $6.6 $59,856 - $153,120	-23,200 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$5.02 - $6.66 $116,463 - $154,512	23,200 New	23,200 $120,000
Q3 2019 Nov 13, 2019	SELL	$4.98 - $6.7 $81,672 - $109,880	-16,400 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$3.15 - $6.95 $51,660 - $113,980	16,400 New	16,400 $103,000

Others Institutions Holding DYAI

# of Institutions

Shares Held

4.77M

Call Options Held

20.6K

Put Options Held

View Full List

About DYADIC INTERNATIONAL INC

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $48.3M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

More about DYAI

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account